print

Correlational findings

Study Constantino et al. (2013): study ZZ Western Europe 2001

Public
FTM transsexuals followed for 5 years since start of treatment, 2001-2008, Netherlands and Germany
Survey name
Unnamed study
Sample
Respondents
N = 50
Non Response
12.3%
Assessment
Questionnaire: Paper & Pencil Interview (PAPI)
Questionnaire completed at hospital visit

Correlate

Authors's Label
Testosterone administration and sex reassignment surgery
Our Classification
Remarks
T1 baseline T2 12 months of testosterone treatment T3 sex reassignment surgery (hysteroannexiectomy and reductive mammoplasty) None of subjects had undergone phalloplasty or any other reconstructive genital surgery. T4 follow up 6 months after sex reassignment surgery
Related specification variables
Operationalization
Treatment consisting of:
T1-T2 testosterone administration
T3 sex reassignment surgery
T4 follow up

Observed Relation with Happiness

Happiness Measure Statistics Elaboration / Remarks A-AOL-cm-sq-?-6-a DMe = + ns Median (25th-75th percentile):
T1: Baseline                1.0 (0.8-2.0)
T2: Month 12 of treatment   1.0 (1.0-2.0)
T4: Post surgery follow-up  2.0 (1.0-2.0)

Change T1-T2 ns
Change T1-T4 ns
A-AOL-cm-sq-?-6-b DMe = 0 ns Median (25th-75th percentile):
T1: Baseline                5.0 (4.0-5.0)
T2: Month 12 of treatment   5.0 (4.0-5.0)
T4: Post surgery follow-up  5.0 (4.0-5.0)

Scale inverted by WDH team

Change T1-T2 ns
Change T1-T4 ns